Clinical Trials for Aplastic Anemia & Myelodysplastic Syndromes
The NIDDK conducts and supports clinical trials in many diseases and conditions, including blood diseases. The trials look to find new ways to prevent, detect, or treat disease and improve quality of life.
What are clinical trials for aplastic anemia and MDS?
Clinical trials—and other types of clinical studies—are part of medical research and involve people like you. When you volunteer to take part in a clinical study, you help doctors and researchers learn more about disease and improve health care for people in the future.
Researchers are studying many aspects of aplastic anemia and MDS, such as
- the efficacy of new combination treatments
- new methods of stem-cell transplant to reduce complications and improve outcomes
- optimal dose of immunosuppressants following stem-cell transplant
Watch a video of NIDDK Director Dr. Griffin P. Rodgers explaining the importance of participating in clinical trials.
What clinical studies for aplastic anemia and MDS are looking for participants?
You can view a filtered list of clinical studies on aplastic anemia and MDS that are federally funded, open, and recruiting at www.ClinicalTrials.gov. You can expand or narrow the list to include clinical studies from industry, universities, and individuals; however, the NIH does not review these studies and cannot ensure they are safe. Always talk with your health care provider before you participate in a clinical study.
This content is provided as a service of the National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK), part of the National Institutes of Health. The NIDDK translates and disseminates research findings to increase knowledge and understanding about health and disease among patients, health professionals, and the public. Content produced by the NIDDK is carefully reviewed by NIDDK scientists and other experts.